Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach
This study explores a model-based meta-analysis (MBMA) and a clinical utility index (CUI) approach to…
CertaraMarch 4, 2025
Machine Learning for PK/PD Modeling in Drug Development
Pharmacometricians can use machine learning for PK/PD modeling to help them characterize the safety and…
CertaraMarch 4, 2025
CDISC data standards – Beyond value [Korean Webinar]
March 13, 2025 - 3:00 pm Korea
CertaraMarch 3, 2025
PBBM Educational Webinar Series (Part 1): The Basics of Drug Absorption in Drug Development – Why is Drug Absorption Essential? [Japanese Webinar]
Part 2 on July 17th : What is the Drug Absorption Model? Part 3 in…
CertaraFebruary 27, 2025
Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis
February 24, 2025 Efficient drug development relies on informed decision-making. For toxicologists, having timely access…
CertaraFebruary 24, 2025
The History of Pinnacle 21
February 21, 2025 It was late 2007. Mad Men was the hottest show on TV.…
CertaraFebruary 21, 2025
